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The literature emphasizes the risk of depression after a stroke. Less well known is the fact that depression may be as big a risk
factor for strokes as hypertension, particularly in the older age group. This article reviews the risk for stroke and cognitive
impairmentconsequenttodepression,anddescribesthecardiovascularandimmunologicalmechanismsthatwouldappeartolink
depression to its cerebrovascular consequences. As well, the article refers to the brain imaging signatures that may allow prediction
of impending brain injury. Finally, some questions that might be explored by future research are suggested, and some practical
means to identify and help those at risk for the development of depression-associated vascular disease of the brain are suggested.
1.Introduction
It is now reliably proven that strokes lead to both depression
and diminished cognitive ability. Perhaps less well known is
the fact that depression is a major risk factor for stroke. This
paper is a selective review of the rapidly expanding literature
linking emotional states to vascular health through their in-
ﬂuence on the immune system. It is the result of multiple lit-
erature searches through PubMed and other search engines
spanning the period from 2000 to 2011. Preference was given
to meta-analyses and large health surveys. The articles in-
cluded in this paper were selected because they contributed
to understanding the mechanisms by which depression may
lead to cognitive impairment through the intermediate step
of vascular damage to the brain and provided new insights
into the mechanisms by which this process may occur.
The paper identiﬁes questions that remain unanswered and
suggests some practical approaches that may help to break
the link suggested in the title.
2. Strokes and Depression
Emerging depression is a common problem after stroke [1].
Thebestestimatesarethatapproximatelyone-thirdofpeople
who have had a stroke will display poststroke depression
[2], which in addition to being characterized by low mood,
alterations in weight, appetite and sleep pattern, is associated
with reduced perception of quality of life and can lead to
suicidal ideation [3, 4].
There would seem to be some gender diﬀerences in the
likelihood of post-stroke depression. Thus, while depression
at baseline in men and women is found to be similar, women
appear more likely to report depression after stroke even
when adjusting for age, stroke severity, and comorbidities
[5]. It is also a matter of debate whether the likelihood of
poststrokedepressionisdeterminedbypremorbidpsychoso-
cial factors, lesion size and location, biologic mechanisms
such as disruption of neurotransmission and release of
cytokines, or a combination of these factors [6].
3. Strokes and CognitiveDecline
It is now well established that cognitive impairment can be
a consequence of brain infarcts. The risk of not attaining
healthy aging, adjusted for age, increased twofold in partic-
ipants with brain infarcts [7]. In the Nun study [8], the pres-
ence of a single lacune at autopsy signiﬁcantly increased
the probability of dementia. Imaging and other studies have
demonstrated that lesions in the white matter are com-
mon,relatedtohypertension,increasetheriskofmildcogni-
tive impairment (MCI), and more than double the risk of2 Cardiovascular Psychiatry and Neurology
dementia [9–12]. The Framingham oﬀspring study showed
that, depending on how extensive the white matter hyperin-
tensities (WMHs) were, the hazard ratio for dementia varied
between 2.22 and 6.12, independently of vascular risk factors
[13]. Nor is cognitive decline limited to small vessel disease
(SVD) and lacunar strokes: 50% of those who suﬀer large
strokes exhibit cognitive deﬁcits within months [14]. Thus,
the assertion that strokes lead to cognitive decline is true for
both large strokes and smaller white matter lesions.
4.DepressionandCognitiveDecline
In a recent systematic review of the factors associated with
cognitive decline in laterlife,Plassmanandhercolleaguesre-
viewed all large observational studies and randomized con-
trolled trials published over 25 years ending in 2009 [15].
Theyconcludedthattherewasindeedanassociationbetween
depression and cognitive decline. K¨ ohler and colleagues re-
ported that half of the patients with major depressive disor-
der exhibited generalized cognitive impairment [16]. This
pattern and course of cognitive impairment in late-life de-
pression conﬁrmed what Dufouil and colleagues had previ-
ously reported: a strong cross-sectional association between
depressive symptomatology and poor cognitive performance
[17, 18]. In 2006, Ganguli and colleagues had also concluded
their 12-year prospective epidemiological study by stating
that depressive symptoms were associated with cognitive im-
pairment [19] .T h u s ,w i t hr a r ee x c e p t i o n s[ 20], the consen-
sus appears to indicate a strong negative inﬂuence of depres-
sion on cognitive function. It is important to keep in mind
that the majority of the studies that found an association
between depression and cognitive deﬁcits determined the
presence of depression through semistructured interviews
rather than clinical evaluations. Thus, observations of apa-
thy, anxiety, and sleep diﬃculties may have been labelled as
depression. Still, the mechanisms that may underlie this as-
sociation between depression and cognitive decline have
recently been receiving a lot of attention.
5. Depression as a Risk Factor for Stroke
The traditional risk factors that lead to strokes are well
known: advancing age, hypertension, smoking, hypercholes-
terolemia, obesity, and diabetes. Less well known is the asso-
ciation between depression and both strokes and dementia,
which is seen in reports from both large cohorts and smaller
observation studies. In a 2005 paper, Williams reviewed all
the studies speciﬁcally linking depressive symptoms with in-
creased risk of strokes and concluded that depression is a
strong risk factor for stroke [21]. In a 6-year prospective
cohortstudyofnearly2500olderadults,Ostirandcolleagues
found that stroke risk increased with the severity of depres-
sion and, conversely, that positive aﬀe c ts c o r e sh a das t r o n g
inverse relationship with stroke [22]. Data from the National
Health and Nutrition Examination Survey (NHANES) like-
wise showed that depression symptoms at baseline were
associated with increased stroke risk even after adjusting for
vascular risk factors [23], while a study by Krishnan and
colleagues, using data from the Leukoaraiosis and Disability
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Figure 1: The pathway from depression to dementia and the mech-
anisms that play a role. Small Vessel disease (SVD) and stroke may
or may not be the exclusive pathway from depression to dementia,
as the upper line suggests.
(LADIS) study, revealed that depression accounted for 12%
of the variance in stroke incidence beyond the contribution
of the vascular risk factors [24]. A Danish study showed that
stroke risk in older patients with depression was increased
by 22%, and the risk was not present in patients with
bipolar disorder, making depression a unique mental state
that leads to strokes [25]. Sarah Vermeer in her review of the
factors associated with brain white matter hyperintensities
reported that the incidence of covert strokes in patients with
depressionwas46%,whilethatinpatientswithhypertension
was 43%, and in individuals with cerebrovascular risk factors
it was 39% [26]. Although one must keep in mind that the
presence of vascular involvement in organs other than brain
may contribute to depression and strokes, these data suggest
that the association between stroke and depression is at least
as strong as that with more traditional risk factors.
The age at which the depression begins appears to inﬂu-
ence the vulnerability to stroke. Herrmann and colleagues
from Oxford University identiﬁed 30 eligible studies inves-
tigating white matter changes in late life depression and con-
cludedfromtheirmeta-analysisthattheoddsofhavingwhite
matter changes were over 4 for late-compared with early-
onset depression [27]. There may also be a gender diﬀerence
in the vulnerability to stroke in the depressed state. In the
Women’s Health Initiative, women with depression but no
history of cardiovascular disease were not at increased risk of
stroke, whereas those with a history of prior cardiovascular
disease were at 45% increased risk of stroke [28]. Nonethe-
less, it is increasingly evident that depression is a strong risk
factor for stroke, but this link may be modulated by both age
and gender.
6. MechanismsLinkingDepressionto
VascularBrainDiseaseandCognitiveDecline
There are intriguing suggestions in the literature as to the
mechanisms that may underlie depression’s role in leading
to strokes and cognitive impairment. These are portrayed in
(Figure 1).
Several authors have highlighted the vascular, metabolic,
and inﬂammatory changes that accompany sadness and de-
pression, and recent imaging studies have added to the
weight of the evidence by suggesting that depression leads
both to weakening of the subcortical white matter and to oc-
clusion of small brain vessels. The following mechanisms
may link depression to vascular disease.Cardiovascular Psychiatry and Neurology 3
6.1. Hemodynamic. The cardiovascular system responds to
our state of mind. Prkachin and colleagues interviewing un-
dergraduate students concluded that systolic and diastolic
b l o o dp r e s s u r e sa sw e l la ss t r o k ev o l u m ed i ﬀerentiated
among emotions [29]. In a study by Sinha and colleagues
which examined the cardiovascular mechanisms governing
diﬀerential blood pressure changes during the emotions of
joy,sadness,fear,andanger,sadnessresultedinadistinctpat-
tern, with moderate increases in blood pressure and vascular
resistance,andadecreaseincardiacoutput[30].Thesechan-
ges correspond to what is known about the vulnerability of
the brain to vascular risk factors: in a comparison of Inter-
stroke and InterHeart data, it was shown that the brain is
far more sensitive to rises in blood pressure than the heart
[31]. Thus, sustained cardiovascular changes of the pattern
reported by Sinha and colleagues may well contribute to the
development of ischemic brain damage.
6.2. Inﬂammatory. Potentially the most relevant mechanism
linking depression to both stroke and cognitive decline is
the response of the immune system to sustained depres-
sion. Dantzer and coworkers reported that interleukin-6,
a major proinﬂammatory cytokine, was increased in the
blood of depressed patients [32], and a recent meta-anal-
ysis concluded that only the basal levels of IL-6 and tum-
our necrosis factor-alpha (TNF-α) were signiﬁcantly raised
in major depression [33]. These ﬁndings led Leonard to sug-
gest that depression arises from a dysfunction of the im-
mune system [34]. Zhu and colleagues have reported that
proinﬂammatory cytokines can acutely regulate neuronal
serotonin [35], thus linking inﬂammatory systems to the
moretraditional understanding oftheneurochemistryofde-
pression, a concept further expanded by Steiner and col-
leagues [36].
If depression is associated with proinﬂammatory cytok-
ines, these same agents are now known to be associated with
cognitive impairment. This link was recently reviewed by
Gorelick [37]. Trollor and colleagues reported from the Syd-
ney Memory and Aging Study that levels of TNF-α and se-
rum amyloid A were higher in participants with MCI than
in cognitively normal individuals [38], conﬁrming earlier
reports to that eﬀect [39, 40]. Their studies however showed
that this association was inﬂuenced by gender. TNF-α has
also been shown to be higher in vascular dementia than
in Alzheimer’s disease [41]. Although the raised level of C-
reactiveprotein(CRP)inindividualswithdementiahasbeen
known for some time [42, 43], a recent study where patients
withTIAorminorstrokewerefollowedfor3monthsshowed
no association between circulating inﬂammatory markers
that included CRP, interleukin-1 receptor antagonist, and
interleukin-6 but not TNF-α and recurrence of the vascular
events [44].
The fact that cytokines are elevated in depression and
cognitive impairment does not necessarily confer to them
an etiologic role in those settings. However, once elevated in
the setting of depression, TNF-α, by reducing endothelial ni-
tric-oxide synthase (eNOS) expression, can lead to neu-
ronal and vascular injury through a decrease in nitric ox-
ide bioavailability and the formation of reactive oxygen spe-
cies.Aswell,TNF-αchangesproteinexpressionand/oractiv-
ity in macrophages and monocytes leading to increased cho-
lesterol uptake and the generation of foam cells. Through
these actions, TNF-α damages endothelial cells leading to
reduced integrity of the endothelial barrier and increased ﬁ-
brinolysis and apoptosis of these cells. As well, it aﬀects vas-
cular smooth muscle cells, leading to their proliferation with
consequent reduction of the vascular caliber. Thus, TNF-α
is a major driver of endothelial dysfunction and atheroscle-
rosis through a variety of mechanisms that were recently
reviewed[45].AlthoughthereviewbyKleinbongardandcol-
leagues referred to here highlighted the role of TNF-α in
determining the size of a myocardial infarct and subsequent
remodelling, many of the pathways identiﬁed are equally
relevant to brain ischemia. These pathological actions of
TNF-α are aggravated by aging, smoking, and obesity, which
are associated with a chronic low-grade increase in TNF-α
[46], suggesting that a positive feedback loop may occur in
some clinical settings that accentuate the vascular damaging
eﬀects of both TNF-α and the more traditional vascular risk
factors.
6.3. Structural Changes. A recent imaging study has shown
that depressed individuals show microstructural brain ab-
normalities in the regions known to be vulnerable to the
development of WMH in the ischemic setting. Investigators,
looking for microstructural changes in midbrain regions in
subjects suﬀering from major depression, reported ﬁnding
whitematterchangesindeepcorticalwhitematterstructures
[47]. These aﬀected regions were not in the investigators’
a priori areas of evaluation, but the intensity of changes in
them could not be ignored, making it likely that depression
leads directly to structural changes in the white matter or at
a minimum can render it more vulnerable to such damage.
Interestingly, the deep cortical white matter is also reported
to suﬀer microstructural abnormalities in normal aging
[48], perhaps indicating why older individuals may be more
vulnerable to the development of WMH in the setting of
depression.
7. Questions for Future Research
Studies reviewed here show strong binary associations be-
tween depression and MCI, between depression and stroke,
and between stroke and MCI. Importantly, the paper makes
strong suggestions on the role the immune system may play
inthepathwayfromdepressiontodementia.Astudyisneed-
ed that can prospectively determine whether the pathway
from depression to MCI is exclusively through vascular brain
damage and what immune biomarkers may be important
players in this sequence. Another assumption that pervades
the literature and could be tested in this study is that depres-
sion causes strokes predominantly through SVD and white
matter rather than cortical injury. This paper also suggests
that the age at which depression starts, its severity, and the
gender of the individual aﬀected are relevant to the subse-
quent development of cognitive impairment. A study such
as the proposed here could not only measure the relative in-
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of depression and their association with dementia, but also
address the roles of age, gender, and the traditional risk
factors in determining the progression from depression to
dementia.
New therapeutic insights would also arise from such a
clinical study. For example, the concept that inﬂammation
is associated with the depressed state of mind and can lead
to vascular and structural injury to the brain has led to the
suggestion that, in the treatment of depression, nonsteroidal
anti-inﬂammatorymedicationinadditiontoantidepressants
may be more eﬀective than antidepressants alone [49, 50].
A more recent and very limited study in stroke patients
reported signiﬁcant improvement in stroke symptoms fol-
lowing the administration of a TNF-α inhibitor [51]. The
study proposed here would not only allow measurement of
inﬂammatory mediators, but may also allow testing whether
the pathway from depression to MCI can be interrupted
concomitant with a decrease in the appearance of WMH and
cognitive decline.
8. Breaking the Cycle from
DepressiontoDementia
The onset of cognitive impairment, especially if associated
with a stroke, would be expected to diminish the prospects
for recovery and increase the burden of care. Antidepressants
may enhance cognitive recovery following stroke, indepen-
dently of their eﬀect on depression [52]. Because of this,
nursing homes and elder care facilities are attempting to
detect depression in their residents and correcting it [53],
so much so that excesses in antidepressant treatments have
been identiﬁed [54]. Martha Daviglus and her colleagues in
an NIH consensus statement reported that whereas the asso-
ciationofcognitivedeclinewithlivingaloneorbeingwithout
a partner is inconsistent, “a robust association exists be-
tween the loss of a spouse and cognitive decline” [55]. This
raises the possibility that individuals who have recently lost
a spouse, provided that ethical boundaries are respected,
may welcome involvement in a structured psychosocial pro-
gram aimed at decreasing the likelihood of depression and
increasingthechancesoftreatment.Depressioninthesetting
of sudden bereavement is an understandable state of mind,
but it does not diminish the fact that it may be harmful to
brain function.
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